SpinalMotion Completes Enrollment in International Clinical Study for Kineflex(R) Lateral Lumbar Disc

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--SpinalMotion, Inc., developer of the investigational Kineflex® lumbar and Kineflex®|C cervical disc implants for treating patients with degenerative disc disease (DDD), today reported that it has completed enrollment in an international clinical study evaluating the Kineflex lumbar artificial disc inserted via a minimally invasive lateral approach. The data from the study will be used to support regulatory submissions for international commercialization.

Back to news